focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,172.00
Bid: 11,500.00
Ask: 12,470.00
Change: 0.00 (0.00%)
Spread: 970.00 (8.435%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Debenhams Raised After Strong Report

Fri, 17th Apr 2015 08:58

LONDON (Alliance News) - The following shares received analyst recommendations Friday morning:
---------
FTSE 100
----------
CANACCORD RAISES SMITHS GROUP PRICE TARGET TO 1410 (1390) PENCE - 'HOLD'
----------
EXANE BNP RAISES SMITHS GROUP PRICE TARGET TO 1150 (1050) PENCE - 'NEUTRAL'
----------
NOMURA RAISES SMITHS GROUP PRICE TARGET TO 1400 (1320) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES SMITHS GROUP PRICE TARGET TO 1520 (1310) PENCE - 'OVERWEIGHT'
----------
EXANE BNP RAISES WEIR GROUP PRICE TARGET TO 1925 (1500) PENCE
----------
EXANE BNP RAISES WEIR GROUP TO 'NEUTRAL' ('UNDERPERFORM')
----------
EXANE BNP CUTS GKN TO 'NEUTRAL' ('OUTPERFORM') - TARGET 380 PENCE
----------
CREDIT SUISSE RAISES WHITBREAD PRICE TARGET TO 6200 (5300) PENCE - 'OUTPERFORM'
----------
CANACCORD RAISES KINGFISHER PRICE TARGET TO 334 (300) PENCE - 'HOLD'
----------
CANACCORD RAISES DIAGEO PRICE TARGET TO 1515 (1465) PENCE - 'SELL'
----------
JPMORGAN RAISES UNILEVER PLC PRICE TARGET TO 2900 (2750) PENCE - 'UNDERWEIGHT'
----------
Liberum Raises Unilever Price Target To 2,400p From 2,310p, Reiterates Sell
----------
JPMORGAN RAISES SABMILLER PRICE TARGET TO 4000 (3650) PENCE - 'OVERWEIGHT'
----------
UBS RAISES SABMILLER PRICE TARGET TO 3600 (3500) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES SABMILLER PRICE TARGET TO 3920 (3700) PENCE - 'BUY'
----------
Berenberg Raises SABMiller Price Target To 3,920p From 3,700p, Reiterates Buy
----------
DAVY INITIATES ROYAL MAIL WITH 'UNDERPERFORM' - TARGET 380 PENCE
----------
GOLDMAN RAISES MEGGITT PRICE TARGET TO 592 (573) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BAE SYSTEMS PRICE TARGET TO 611 (577) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES ASTRAZENECA PRICE TARGET TO 4850 (4800) PENCE - 'HOLD'
----------
DEUTSCHE BANK RAISES SHIRE PRICE TARGET TO 5900 (5700) PENCE - 'BUY'
----------
FTSE 250
----------
EXANE BNP RAISES MELROSE INDUSTRIES TARGET TO 315 (300) PENCE - 'OUTPERFORM'
----------
CANACCORD CUTS PETRA DIAMONDS PRICE TARGET TO 220 (230) PENCE - 'BUY'
----------
EXANE BNP CUTS VESUVIUS PRICE TARGET TO 515 (540) PENCE - 'OUTPERFORM'
----------
EXANE BNP RAISES SPIRAX-SARCO PRICE TARGET TO 3550 (3500) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS ROTORK PRICE TARGET TO 2600 (2610) PENCE - 'NEUTRAL'
----------
BARCLAYS CUTS ROTORK TO 'EQUAL WEIGHT' ('OVERWEIGHT')
----------
EXANE BNP RAISES IMI PRICE TARGET TO 1150 (1100) PENCE - 'UNDERPERFORM'
----------
EXANE BNP RAISES HALMA PRICE TARGET TO 800 (780) PENCE - 'OUTPERFORM'
----------
EXANE BNP RAISES SPECTRIS TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 2375 (1850) PENCE
----------
BARCLAYS RAISES SPECTRIS PRICE TARGET TO 2535 (2065) PENCE - 'OVERWEIGHT'
----------
CREDIT SUISSE RAISES JUPITER FUND PRICE TARGET TO 430 (378) PENCE - 'NEUTRAL'
----------
MORGAN STANLEY RAISES PLAYTECH PRICE TARGET TO 1030 (960) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS CARILLION PRICE TARGET TO 305 (330) PENCE - 'NEUTRAL'
----------
PANMURE RAISES PROVIDENT FINANCIAL PRICE TARGET TO 3000 (2700) PENCE - 'HOLD'
----------
SOCGEN RAISES DEBENHAMS PRICE TARGET TO 80 (67) PENCE - 'HOLD'
----------
UBS RAISES DEBENHAMS PRICE TARGET TO 90 (85) PENCE - 'BUY'
----------
CITIGROUP RAISES DEBENHAMS TO 'BUY' ('NEUTRAL') - TARGET 95 (75) PENCE
----------
BARCLAYS RAISES MORGAN ADVANCED MATERIALS TARGET TO 350 (305) PENCE - 'EQUALWEIGHT'
----------
BARCLAYS RAISES LAIRD PRICE TARGET TO 370 (315) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES IMI PRICE TARGET TO 1380 (1340) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES HALMA PRICE TARGET TO 715 (650) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS CUTS DOMINO PRINTING TO 'EQUAL WEIGHT' ('OVERWEIGHT')
----------
BARCLAYS RAISES DOMINO PRINTING PRICE TARGET TO 915 (730) PENCE
----------
BARCLAYS RAISES RENISHAW PRICE TARGET TO 2825 (2425) PENCE - 'OVERWEIGHT'
----------
GOLDMAN RAISES QINETIQ PRICE TARGET TO 208 (204) PENCE - 'NEUTRAL'
----------
BARCLAYS RAISES QINETIQ TO 'OVERWEIGHT' ('EQUAL WEIGHT') - TARGET 220 (210) PENCE
----------
BARCLAYS INITIATES MONEYSUPERMARKET WITH 'OVERWEIGHT' - TARGET 315 PENCE
----------
TRADERS: HSBC RAISES PENNON GROUP PRICE TARGET TO 970 (960) PENCE
----------
GOLDMAN CUTS ULTRA ELECTRONICS PRICE TARGET TO 1833 (2011) PENCE - 'NEUTRAL'
----------
GOLDMAN RESUMES COBHAM WITH 'NEUTRAL' - TARGET 329 PENCE
----------
GOLDMAN CUTS PETROFAC TO 'BUY' ('CONVICTION BUY LIST') - TARGET 1130 PENCE
----------
GOLDMAN RAISES HUNTING TO 'CONVICTION BUY' ('BUY') - TARGET 709 (622) PENCE
----------
MAIN MARKET AND AIM
----------
CANACCORD RAISES ONESAVINGS BANK TO 'BUY' ('HOLD') - TARGET 316 (290) PENCE
----------
JPMORGAN CUTS MOTHERCARE PRICE TARGET TO 235 (239) PENCE - 'OVERWEIGHT'
----------
JPMORGAN INITIATES URBAN & CIVIC WITH 'NEUTRAL' - TARGET 300 PENCE
----------
Cantor Fitzgerald Raises Chariot Oil & Gas Price Target To 20p From 12p, Reiterates Buy
----------
BARCLAYS RAISES OXFORD INSTRUMENTS PRICE TARGET TO 1000 (860) PENCE
----------
BARCLAYS RAISES OXFORD INSTRUMENTS TO 'OVERWEIGHT' ('EQUAL WEIGHT')
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more
1 Dec 2023 07:41

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

Read more
27 Nov 2023 16:12

London close: Stocks start week in subdued state

(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.

Read more
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more
20 Nov 2023 10:49

AstraZeneca launches new life sciences tech innovation firm Evinova

(Alliance News) - AstraZeneca PLC on Monday launched Evinova, a new health technology business focused on accelerating innovation across the life sciences sector, delivery of clinical trials and better health outcomes.

Read more
17 Nov 2023 15:20

London close: Stocks higher despite weaker retail sales data

(Sharecast News) - London's stock markets finished in a positive state on Friday despite weaker-than-expected UK retail sales figures.

Read more
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more
17 Nov 2023 09:03

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK.

Read more
17 Nov 2023 08:31

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
17 Nov 2023 07:16

AstraZeneca gets US approval for breast cancer treatment

(Sharecast News) - AstraZeneca's 'Truqap', or capivasertib, in combination with 'Faslodex', or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.

Read more
14 Nov 2023 10:51

TOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trial

(Alliance News) - AstraZeneca PLC on Tuesday said the Pacific-2 phase III trial for Imfinzi as an early treatment lung cancer immunotherapy treatment administered with chemoradiotherapy, did not meet its primary endpoint.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.